The University of Kentucky Markey Cancer Center is one of 22 cancer centers nationwide to receive funding to build and implement tobacco cessation treatment programs via the National Cancer Institute's Cancer Center Cessation Initiative (CCCI).
New findings from University of Kentucky faculty published in Scientific Reports reveals a novel cell signaling interaction that may prevent a key step in lung cancer progression.
Kip Guy shares his research on neglected diseases, his goals as dean of the College of Pharmacy, and how pharmacy researchers are addressing the opioid epidemic.
The University of Kentucky Markey Cancer Center has joined the Oncology Research Information Exchange Network® (ORIEN), a personalized medicine consortium that allows its members to exchange data and push forward evidence-based cancer care to patients.
University of Kentucky Markey Cancer Center Researcher Jessica Blackburn has earned a prestigious National Institutes of Health's New Innovator Award, a grant totaling $1.5 million over five years to fund pediatric cancer research.
Many cancer survivors experience devastating cognitive impairment following chemotherapy. Researchers at UK are trying to identify strategies to relieve these symptoms.
In a new phase III trial report, recurrence and survival rates for women with stage I-II high-risk endometrial cancer were not superior following vaginal cuff brachytherapy & chemotherapy when compared with pelvic radiation therapy.
A new study by University of Kentucky Markey Cancer Center researchers shows that when therapy-sensitive cancer cells die, they release a "killer peptide" that can eliminate therapy-resistant cells.
